NAMS · NewAmsterdam Pharma Co N.V.
Market Cap
$3.04B
Shares
119.54M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1936258
CUSIP
N62509109
13F (30d)
131 filings
131 filers
Visit website
Investor relations